Search Results

There are 937 results for: content related to: Cardiac implications for the use of β 2 -adrenoceptor agonists for the management of muscle wasting

  1. You have free access to this content
    Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates, Roman Jaeschke, Stefanie Schmidt and Montse Ferrer

    Published Online : 7 JUN 2013, DOI: 10.1002/14651858.CD006924.pub3

  2. You have free access to this content
    Long-acting beta2-agonists for chronic obstructive pulmonary disease

    Intervention Review

    The Cochrane Library

    Kayleigh M Kew, Chris Mavergames and Julia AE Walters

    Published Online : 15 OCT 2013, DOI: 10.1002/14651858.CD010177.pub2

  3. Regular treatment with formoterol for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Matthew J Cates

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006923.pub3

  4. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Toby J Lasserson

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD007085.pub2

  5. You have free access to this content
    Cochrane review: Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 5, Issue 3, September 2010, Pages: 1456–1542, Christopher J Cates, Toby J Lasserson and Roman Jaeschke

    Version of Record online : 7 OCT 2010, DOI: 10.1002/ebch.583

  6. You have free access to this content
    Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Christopher J Cates, L. Susan Wieland, Marta Oleszczuk and Kayleigh M Kew

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD010314.pub2

  7. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma

    Intervention Review

    The Cochrane Library

    Emma J Welsh and Christopher J Cates

    Published Online : 8 SEP 2010, DOI: 10.1002/14651858.CD008418.pub2

  8. Efficacy and safety of high-dose budesonide/formoterol (Symbicort®) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma

    Respirology

    Volume 11, Issue 3, May 2006, Pages: 276–286, Christine JENKINS, Renata KOLARIKOVA, Piotr KUNA, Denis CAILLAUD, Joaquin SANCHIS, Wolfgang POPP and Eva PETTERSSON

    Version of Record online : 19 APR 2006, DOI: 10.1111/j.1440-1843.2006.00856.x

  9. You have free access to this content
    Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma

    Allergy

    Volume 63, Issue 12, December 2008, Pages: 1567–1580, M. Humbert, T. L. G. Andersson and R. Buhl

    Version of Record online : 12 NOV 2008, DOI: 10.1111/j.1398-9995.2008.01863.x

  10. You have free access to this content
    Aclidinium bromide for stable chronic obstructive pulmonary disease

    Intervention Review

    The Cochrane Library

    Han Ni, Zay Soe and Soe Moe

    Published Online : 19 SEP 2014, DOI: 10.1002/14651858.CD010509.pub2

  11. You have free access to this content
    Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Kayleigh M Kew, Sofia Dias and Christopher J Cates

    Published Online : 26 MAR 2014, DOI: 10.1002/14651858.CD010844.pub2

  12. You have free access to this content
    Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Christopher J Cates, Marta Oleszczuk, Elizabeth Stovold and L. Susan Wieland

    Published Online : 17 OCT 2012, DOI: 10.1002/14651858.CD010005.pub2

  13. You have free access to this content
    Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human

    British Journal of Clinical Pharmacology

    Volume 54, Issue 3, September 2002, Pages: 246–250, Mei Zhang, J. Paul Fawcett and John P. Shaw

    Version of Record online : 18 SEP 2002, DOI: 10.1046/j.1365-2125.2002.01641.x

  14. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: Phase III study results

    Respirology

    Volume 18, Issue 2, February 2013, Pages: 354–363, TITO ATIENZA, TERESITA AQUINO, MARCELO FERNÁNDEZ, WATCHARA BOONSAWAT, MITSURU KAWAI, TAKAHIDE KUDO, Jan Ekelund, Stefan Ivanov and Lars-Goran Carlsson

    Version of Record online : 25 JAN 2013, DOI: 10.1111/resp.12009

  15. Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPD

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1300–1308, Dr Ann Tronde, Mr Michael Gillen, Dr Lars Borgström, Dr Jan Lötvall and Dr Jaro Ankerst

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008322122

  16. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Toby J Lasserson

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD007694.pub2

  17. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: Phase III multinational study results

    Respirology

    Volume 18, Issue 5, July 2013, Pages: 866–873, Yoshinosuke Fukuchi, Ronnie Samoro, Rustem Fassakhov, Hiroyuki Taniguchi, Jan Ekelund, Lars-Goran Carlsson and Masakazu Ichinose

    Version of Record online : 21 JUN 2013, DOI: 10.1111/resp.12090

  18. You have full text access to this OnlineOpen article
    Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma

    International Journal of Clinical Practice

    Volume 61, Issue 11, November 2007, Pages: 1874–1883, A. H. Morice, S. Peterson, O. Beckman and D. Osmanliev

    Version of Record online : 10 OCT 2007, DOI: 10.1111/j.1742-1241.2007.01574.x

  19. Dose-related efficacy and safety of formoterol (Oxis®) Turbuhaler® compared with salmeterol Diskhaler® in children with asthma

    Pediatric Allergy and Immunology

    Volume 15, Issue 1, February 2004, Pages: 32–39, Petr Pohunek, Milan Matulka, Ondřej Rybníček, František Kopřiva, Helena Honomichlová and Tamara Svobodová

    Version of Record online : 1 MAR 2004, DOI: 10.1046/j.0905-6157.2003.00096.x

  20. You have free access to this content
    Stereoselective glucuronidation of formoterol by human liver microsomes

    British Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2000, Pages: 152–157, Mei Zhang, J. Paul Fawcett, Julia M. Kennedy and John P. Shaw

    Version of Record online : 5 APR 2002, DOI: 10.1046/j.1365-2125.2000.00133.x